CTKB - Cytek Biosciences Chief Technology Officer Trades Company's Stock | Benzinga
Ming Yan, Chief Technology Officer at Cytek Biosciences (NASDAQ:CTKB), reported a large insider sell on October 24, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that Yan sold 20,000 shares of Cytek Biosciences. The total transaction amounted to $96,000.
Cytek Biosciences shares are trading down 1.08% at $4.57 at the time of this writing on Tuesday morning.
Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.
The Importance of Insider Transactions
Insider transactions shouldn't be used primarily to make an investing decision, ...